Abstract: A motion analysis device presents a factor to be aware in performing a motion. The motion analysis device includes a trained model trained so as to take as input-time-series information about a motion performed to achieve a specific target, and provide as output result information about a result from the motion, a receiver that receives target time-series information about a target motion to be analyzed, an extractor that extracts, based on result information estimated by inputting the received target time-series information into the trained model, descriptive information indicating a factor in the target motion contributing to the estimated result information, and an output unit that outputs information about a result of analysis of the target motion based on the extracted descriptive information.

Abstract: Provided is a semiconductor module, including: a first switching device provided in one of an upper arm or a lower arm; a second switching device provided in another of the upper arm or the lower arm; a first diode device provided in parallel with the first switching device; a second diode device provided in parallel with the second switching device; a laminated substrate of which a main surface has two sides extending in a predetermined first direction and a predetermined second direction; and a gate external terminal and an auxiliary source external terminal provided farther toward a negative side of the first direction than the upper arm and the lower arm, and arranged in the second direction.

Abstract: The present invention provides a non-human mammal deficient in the expression of the SLC-1 gene, having the characteristics of (1) a lower blood insulin level in glucose tolerance test, (2) increased insulin sensitivity, (3) higher resistance to obesity even on high fat diet, (4) a smaller white fat cell size, and (5) accentuated lipolysis, compared with the corresponding wild-type animal, or a portion of the body thereof. Also provided is an obesity and/or type II diabetes model non-human mammal that is deficient in the expression of the SLC-1 gene, having the characteristics of (1) elevated expression of adiponectin, (2) delayed onset of hyperglycemia, (3) a lower blood glycohemoglobin level, and (4) accentuated energy consumption, compared with the corresponding obesity and/or type II diabetes model non-human mammal wherein the expression of the gene is normal, or a portion of the body thereof.

Abstract: The present invention provides a non-human mammal, or a part of its living body, which stably retains a DNA encoding a heterologous PPAR? in an expressible state, and has one or more different genetic modifications resulting in a pathological condition identical or similar to a disease associated with the regulation of PPAR? activity or a foreign DNA under the control of a promoter having PPRE, as well as a method of screening for agonists/antagonists for the heterologous PPAR? using the animal.

Abstract: A dihydroxy(3-pyridyl)borane compound of the formula (1): wherein R1 represents a hydrogen atom, halogen atom or alkoxycarbonylamino group; R2 represents a hydrogen atom, halogen atom, alkyl group or fluoroalkyl group; with the proviso that the case wherein both R1 and R2 are hydrogen atoms is excepted.

Abstract: A dihydroxy(3-pyridyl)borane compound of the formula (1): 1